- Home
- PLUR vs ONCY Comparison
PLUR vs ONCY Comparison
Compare PLUR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- ONCY
- Stock Information
- Founded
- PLUR 2001
- ONCY 1998
- Country
- PLUR Israel
- ONCY Canada
- Employees
- PLUR N/A
- ONCY N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- ONCY Pharmaceuticals and Biotechnology
- Sector
- PLUR Health Care
- ONCY Health Care
- Exchange
- PLUR Nasdaq
- ONCY Nasdaq
- Market Cap
- PLUR 41.9M
- ONCY 49.1M
- IPO Year
- PLUR N/A
- ONCY 1999
- Fundamental
- Price
- PLUR $5.88
- ONCY $0.91
- Analyst Decision
- PLUR Strong Buy
- ONCY Strong Buy
- Analyst Count
- PLUR 1
- ONCY 4
- Target Price
- PLUR $12.00
- ONCY $4.33
- AVG Volume (30 Days)
- PLUR 62.9K
- ONCY 1.4M
- Earning Date
- PLUR 05-13-2025
- ONCY 07-31-2025
- Dividend Yield
- PLUR N/A
- ONCY N/A
- EPS Growth
- PLUR N/A
- ONCY N/A
- EPS
- PLUR N/A
- ONCY N/A
- Revenue
- PLUR $1,034,000.00
- ONCY N/A
- Revenue This Year
- PLUR $472.39
- ONCY N/A
- Revenue Next Year
- PLUR $254.29
- ONCY N/A
- P/E Ratio
- PLUR N/A
- ONCY N/A
- Revenue Growth
- PLUR 203.23
- ONCY N/A
- 52 Week Low
- PLUR $3.33
- ONCY $0.33
- 52 Week High
- PLUR $7.13
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- PLUR 66.26
- ONCY 78.49
- Support Level
- PLUR $4.61
- ONCY $0.71
- Resistance Level
- PLUR $5.40
- ONCY $0.81
- Average True Range (ATR)
- PLUR 0.55
- ONCY 0.09
- MACD
- PLUR 0.13
- ONCY 0.02
- Stochastic Oscillator
- PLUR 91.46
- ONCY 90.48
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.